Consistent with these in vitro findings, we observed an increase in IRF5 expression in GC B cells in vivo early in disease development, prior to the appearance of overt signs of autoimmunity, with even larger increases evident in plasmablasts and bone marrow plasma cells. The gene discussed is IRF5; the disease is Autoimmunity.